Treating carpal tunnel syndrome can be a costly and intimidating procedure for anyone who chooses to go the route of a carpal tunnel release. This study aims to analyze decision making in hypothetical carpal tunnel syndrome; particularly looking at if they should get treatment and their opinions on healthcare costs.
This will be an interventional clinical trial and will have an estimated enrollment of 1700 participants. It will be a double-blind, randomized, parallel assessment where participants are placed into 1 of 2 study arms: a control arm or an intervention arm. A random block generator will be used in assigning participants to either arm.
- Those presenting to hand clinic OR Mturk workers
- Ages 18 or older
- Those who have suffered a traumatic mechanism of injury
You may participate in this study at Stanford Health Care, located in Redwood City, California.
This study is sponsored by Stanford University by the Principal Investigator, Robert N. Kamal, MD. If you have any questions, please contact Sara Eppler via phone at 650-724-6935 or via email at email@example.com.